CLDX vs XLK
Celldex Therapeutics Inc (CLDX) versus Technology Select Sector SPDR® Fund (XLK) — a side-by-side from cached financials, not a winner call.
Celldex Therapeutics Inc (CLDX) is a biotechnology company listed on US.
Technology Select Sector SPDR® Fund (XLK) common stock listed on US.
Latest reported CLDX revenue for 2026-06-30 was $37.0K. Net income was -$152.2M. CLDX currently screens at market cap $2.35B.
XLK does not have a complete income-statement cache yet.
CLDX currently screens at market cap $2.35B. XLK currently screens at market cap $0.
Not investment advice. Open the CLDX and XLK stock pages for the full models.
Not investment advice.